We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-0.51%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$61.6B
AUM Growth
+$1.91B
(+3.2%)
Cap. Flow
+$2.64B
Cap. Flow
% of AUM
4.28%
Top 10 Holdings %
Top 10 Hldgs %
19.17%
Holding
769
New
56
Increased
370
Reduced
204
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$259M |
| 2 |
Liberty Media Series C
FWONK
|
+$253M |
| 3 |
Oracle
ORCL
|
+$232M |
| 4 |
Avery Dennison
AVY
|
+$230M |
| 5 |
Emerson Electric
EMR
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$236M |
| 2 |
Liberty Media Series A
FWONA
|
+$224M |
| 3 |
State Street
STT
|
+$220M |
| 4 |
Parker-Hannifin
PH
|
+$185M |
| 5 |
Lear
LEA
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.21% |
| 2 | Technology | 15.31% |
| 3 | Healthcare | 14.81% |
| 4 | Energy | 10.39% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISBC
276
DELISTED
Investors Bancorp, Inc.
ISBC
| $21.5M | 0.03% |
2,122,966
+476,236
| +29% | +$5.03M |
|
|
RPXC
277
DELISTED
RPX Corporation
RPXC
| $21.3M | 0.03% |
1,550,427
+35,067
| +2% | +$546K |
|
278
Hanover Insurance
THG
$7.63B
| $20.7M | 0.03% |
336,902
+9,369
| +3% | +$582K |
|
|
CLDT
279
Chatham Lodging
CLDT
$630M
| $20.7M | 0.03% |
896,046
+367,429
| +70% | +$8.2M |
|
280
Sportsman's Warehouse
SPWH
$43.7M
| $20.4M | 0.03% |
3,023,345
-79,371
| -3% | -$508K |
|
281
ABM Industries
ABM
$2.8B
| $20.3M | 0.03% |
789,072
+410,533
| +108% | +$10.8M |
|
282
Integra LifeSciences
IART
$1.54B
| $20.3M | 0.03% |
998,591
-1,473,124
| -60% | -$29.3M |
|
283
Nelnet
NNI
$4.79B
| $19.6M | 0.03% |
453,743
-33,425
| -7% | -$1.43M |
|
284
FerroAtlántica
GSM
$628M
| $19.5M | 0.03% |
1,074,335
-42,631
| -4% | -$849K |
|
|
ACRE
285
Ares Commercial Real Estate
ACRE
$252M
| $19.3M | 0.03% |
1,654,604
+414,651
| +33% | +$5.15M |
|
286
Accuray
ARAY
$28.4M
| $19.3M | 0.03% |
2,652,460
+219,600
| +9% | +$1.78M |
|
287
Nu Skin
NUS
$247M
| $19.2M | 0.03% |
426,117
+236,152
| +124% | +$12.6M |
|
|
OB
288
DELISTED
Onebeacon Insurance Group Ltd
OB
| $19.1M | 0.03% |
1,239,767
+219,687
| +22% | +$3.45M |
|
289
Upbound Group
UPBD
$1.19B
| $19M | 0.03% |
627,310
+17,888
| +3% | +$481K |
|
|
SMA
290
DELISTED
SYMMETRY MEDICAL INC
SMA
| $19M | 0.03% |
1,882,804
-295,030
| -14% | -$2.73M |
|
|
LPNT
291
DELISTED
LifePoint Health, Inc.
LPNT
| $18.9M | 0.03% |
273,485
-16,259
| -6% | -$1.14M |
|
|
LBY
292
DELISTED
Libbey, Inc.
LBY
| $18.9M | 0.03% |
718,706
-288,784
| -29% | -$7.61M |
|
293
Alphabet (Google) Class C
GOOG
$3.9T
| $18.8M | 0.03% |
642,640
+270,942
| +73% | +$7.83M |
|
|
ROSE
294
DELISTED
ROSETTA RESOURCES INC
ROSE
| $18.7M | 0.03% |
419,623
-668,723
| -61% | -$33.3M |
|
295
Petrobras Class A
PBR.A
$107B
| $18.7M | 0.03% |
1,252,822
-213,571
| -15% | -$3.8M |
|
|
PRXL
296
DELISTED
Parexel International Corp
PRXL
| $18.6M | 0.03% |
294,805
+10,047
| +4% | +$573K |
|
297
Take-Two Interactive
TTWO
$43B
| $18.6M | 0.03% |
804,874
+47,194
| +6% | +$1.07M |
|
|
GLDD
298
DELISTED
Great Lakes Dredge & Dock
GLDD
| $18.6M | 0.03% |
3,004,450
+1,235,040
| +70% | +$9.12M |
|
299
Walker & Dunlop
WD
$1.65B
| $18.3M | 0.03% |
1,377,499
+32,266
| +2% | +$448K |
|
300
Baidu
BIDU
$35.8B
| $18.3M | 0.03% |
83,749
-20,589
| -20% | -$4.35M |
|
Similar funds
Boston Partners's Q3 2014 Portfolio in Review
As of Q3 2014, Boston Partners held 769 positions worth $61.6B, up 3.2% from $59.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Boston Partners deployed $2.64B of net new capital in Q3 2014, opening 56 new positions and adding to 370 existing holdings. Its largest new stake was Liberty Media Series C: 9,903,335 shares worth $249M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was ROCK-TENN COMPANY CL-A, an estimated $236M trimmed.
- Boston Partners's largest Q3 2014 buy was Liberty Media Series C: 9,903,335 shares worth $249M.
- Boston Partners added most to Teva Pharmaceuticals in Q3 2014, an estimated $259M increase.
- Boston Partners's biggest Q3 2014 reduction was ROCK-TENN COMPANY CL-A, cutting an estimated $236M.
- Boston Partners fully exited Cigna in Q3 2014, selling an estimated $133M.
- Boston Partners's ten largest holdings make up 19% of its $61.6B portfolio in Q3 2014.
- Boston Partners opened 56 new positions and closed 51 in Q3 2014.
- Boston Partners's portfolio value rose 3.2% quarter-over-quarter to $61.6B.
Based on Boston Partners's 13F filing for Q3 2014, filed 12 Nov 2014.